Please wait

Exhibit 107

CALCULATION OF FILING FEE TABLE

Form 424(b)(5)

(Form Type)

Nurix Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

                 
     Security
Type		  

Title of Each
Class of
Securities

to be
Registered

   Fee
Calculation
Rule		   Amount to
be
 Registered(1) 		   Proposed
Maximum
Offering
Price Per
Share		   Maximum
Aggregate
Offering Price		   Fee Rate   Amount of
Registration
Fee(2)
                 
Fees to be Paid   Equity   Common stock, par value $0.001 per share  

Rule 457(c) and

Rule 457(r)

   —   —   $300,000,000   0.00015310   $45,930
                 
Fees
Previously
Paid		   —   —   —   —   —   —   —   —
           
    Total Offering Amounts   —   $300,000,000   —   $45,930
           
    Total Fees Previously Paid   —   —   —   —
           
    Total Fee Offsets   —   —   —   —
           
    Net Fee Due   —   —   —   $45,930

 

(1)

Consists of shares to be issued pursuant to that certain Equity Distribution Agreement dated August 4, 2021 (as amended by Amendment No. 1 dated July 11, 2024, and as further amended by Amendment No. 2 dated October 31, 2024), by and between the Registrant and Piper Sandler & Co.

 

(2)

Calculated in accordance with Rule 457(c) and Rule 457(r) under the Securities Act of 1933, as amended. Represents payment of registration fees previously deferred in connection with the automatic registration statement on Form S-3 (Registration No. 333-280117).